PlantoneDIngleseMSalvettiM, et al. A perspective of coagulation dysfunction in multiple sclerosis and in experimental allergic encephalomyelitis. Front Neurol2019; 9: 1175.
2.
DavalosDMahajanKRTrappBD.Brain fibrinogen deposition plays a key role in MS pathophysiology – Yes. Mult Scler2019; 25: 1434–1435.
3.
GöbelKMeuthSG.Brain fibrinogen deposition plays a key role in MS pathophysiology – No. Mult Scler2019; 25: 1436–1437.
4.
PetersenMARyuJKAkassoglouK.Fibrinogen in neurological diseases: Mechanisms, imaging and therapeutics. Nat Rev Neurosci2018; 19(5): 283–301.
5.
RyuJKPetersenMAMurraySG, et al. Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation. Nat Commun2015; 6: 8164.
6.
RyuJKRafalskiVAMeyer-FrankeA, et al. Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nat Immunol2018; 19(11): 1212–1223.
7.
GobelKKraftPPankratzS, et al. Prothrombin and factor X are elevated in multiple sclerosis patients. Ann Neurol2016; 80(6): 946–951.
8.
GobelKEichlerSWiendlH, et al. The coagulation factors fibrinogen, thrombin and Factor XII in inflammatory disorders – A systematic review. Front Immunol2018; 9: 1731.
9.
GobelKPankratzSAsaridouCM, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun2016; 7: 11626.
10.
DelvaeyeMConwayEM.Coagulation and innate immune responses: Can we view them separately?Blood2009; 114(12): 2367–2374.